Inicio Zine News Akorn Receives FDA Approval for Betamethasone Dipropionate Lotion USP (Augmented), 0.05%

Akorn Receives FDA Approval for Betamethasone Dipropionate Lotion USP (Augmented), 0.05%

104
0

LAKE FOREST, Ill., Oct. 14, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today announced that it received a new Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration (FDA) for betamethasone dipropionate lotion USP (augmented), 0.05%. The product is manufactured at Akorn’s Amityville, New York manufacturing facility.